In September 2025, the FDA issued over 50 warning letters to companies marketing compounded GLP-1 products with misleading claims
Gastroparesis Gastroparesis, or stomach paralysis, is when your stomach stops the movement of food from your stomach to your intestines, despite no obvious obstruction
Weight loss statistics referenced on this website are from published clinical trials conducted on branded FDA-approved medications, not compounded formulations
The exact duration depends on the individual, the type and dose of medication they take, and how quickly they increase their GLP-1 dose
In addition, in the vast majority of these studies, liraglutide was used at low or medium doses, while it is well known that some effects, in particular weight loss, are dose-dependent and more pronounced at the maximum dose
10.1210/clinem/dgaf401 J Clin Endocrinol Metab